---
figid: PMC9290708__APT-54-1243-g002
figtitle: 'Review article: therapeutic aspects of bile acid signalling in the gut‐liver
  axis'
organisms:
- Mus musculus
- Rattus norvegicus
- Homo sapiens
- Saccharomyces cerevisiae
- gut metagenome
- Erebia epipsodea
- NA
pmcid: PMC9290708
filename: APT-54-1243-g002.jpg
figlink: /pmc/articles/PMC9290708/figure/apt16602-fig-0003/
number: F3
caption: 'Bile acid gut‐liver axis signalling modulates the enterohepatic circulation,
  bile acid synthesis and glucose homeostasis. (i) Enterohepatic circulation of bile
  acids (BA) is contingent on four important transporters in the gut‐liver axis: ASBT,
  OST‐α/‐β, NTCP and BSEP. ASBT mediates BA uptake from the intestinal lumen (primarily
  ileum), whereas OST‐α/‐β releases BAs into the portal circulation. Ileal bile acid
  binding protein (IBABP) binds intracellular BAs and protects enterocytes from BA
  toxicity. NTCP facilitates BA uptake from sinusoidal blood into hepatocytes, and
  BSEP mediates BA secretion into bile canaliculi. Activation of FXR downregulates
  ASBT and NTCP and upregulates OST‐α/‐β, BSEP and IBABP (indicated in red and green
  color). (ii) Bile acid synthesis is regulated by the enterohepatic FXR‐FGF19 pathway,
  and the intrahepatic FXR‐SHP pathway. Activation of FXR in the intestines (primarily
  in the ileum) leads to release of FGF19 into the portal circulation, which represses
  BA synthesis (CYP7A1 gene) by binding to FGFR4/KLB (‘enterohepatic’ feedback signalling).
  Activation of FXR in hepatocytes induces expression of SHP, which acts as a transrepressor
  of genes for BA synthesis (“intrahepatic” feedback signalling). (iii) Activation
  of TGR5 on intestinal L‐cells induces release of GLP‐1, which induces insulin secretion
  and enhances glucose tolerance. Abbreviations: (ASBT) apical sodium dependent bile
  acid transporter; (BA) bile acids; (BSEP) bile salt export pump; (FXR) farnesoid
  X receptor; (FGF19) fibroblast growth factor 19; (FGFR4) FGF receptor 4; (GLP‐1)
  glucagon‐like peptide‐1; (IBABP) ileal bile acid binding protein; (KLB) beta‐klotho;
  (NTCP) sodium/taurocholate cotransporting polypeptide; (OST‐α/‐β) organic solute
  transporter alpha and beta; (SHP) small heterodimer partner; (TGR5) transmembrane
  G protein‐coupled receptor‐5'
papertitle: 'Review article: therapeutic aspects of bile acid signalling in the gut‐liver
  axis.'
reftext: Benedikt Simbrunner, et al. Aliment Pharmacol Ther. 2021 Nov;54(10):1243-1262.
year: '2021'
doi: 10.1111/apt.16602
journal_title: Alimentary Pharmacology & Therapeutics
journal_nlm_ta: Aliment Pharmacol Ther
publisher_name: John Wiley and Sons Inc.
keywords: ''
automl_pathway: 0.9449192
figid_alias: PMC9290708__F3
figtype: Figure
organisms_ner:
- Mus musculus
- Rattus norvegicus
- Homo sapiens
redirect_from: /figures/PMC9290708__F3
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9290708__APT-54-1243-g002.html
  '@type': Dataset
  description: 'Bile acid gut‐liver axis signalling modulates the enterohepatic circulation,
    bile acid synthesis and glucose homeostasis. (i) Enterohepatic circulation of
    bile acids (BA) is contingent on four important transporters in the gut‐liver
    axis: ASBT, OST‐α/‐β, NTCP and BSEP. ASBT mediates BA uptake from the intestinal
    lumen (primarily ileum), whereas OST‐α/‐β releases BAs into the portal circulation.
    Ileal bile acid binding protein (IBABP) binds intracellular BAs and protects enterocytes
    from BA toxicity. NTCP facilitates BA uptake from sinusoidal blood into hepatocytes,
    and BSEP mediates BA secretion into bile canaliculi. Activation of FXR downregulates
    ASBT and NTCP and upregulates OST‐α/‐β, BSEP and IBABP (indicated in red and green
    color). (ii) Bile acid synthesis is regulated by the enterohepatic FXR‐FGF19 pathway,
    and the intrahepatic FXR‐SHP pathway. Activation of FXR in the intestines (primarily
    in the ileum) leads to release of FGF19 into the portal circulation, which represses
    BA synthesis (CYP7A1 gene) by binding to FGFR4/KLB (‘enterohepatic’ feedback signalling).
    Activation of FXR in hepatocytes induces expression of SHP, which acts as a transrepressor
    of genes for BA synthesis (“intrahepatic” feedback signalling). (iii) Activation
    of TGR5 on intestinal L‐cells induces release of GLP‐1, which induces insulin
    secretion and enhances glucose tolerance. Abbreviations: (ASBT) apical sodium
    dependent bile acid transporter; (BA) bile acids; (BSEP) bile salt export pump;
    (FXR) farnesoid X receptor; (FGF19) fibroblast growth factor 19; (FGFR4) FGF receptor
    4; (GLP‐1) glucagon‐like peptide‐1; (IBABP) ileal bile acid binding protein; (KLB)
    beta‐klotho; (NTCP) sodium/taurocholate cotransporting polypeptide; (OST‐α/‐β)
    organic solute transporter alpha and beta; (SHP) small heterodimer partner; (TGR5)
    transmembrane G protein‐coupled receptor‐5'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Gusb
  - Cyp7a1
  - Fgfr4
  - Klb
  - Fgf15
  - Ttn
  - Nr1h4
  - Lce1l
  - Abcb11
  - Gcg
  - Ell
  - Nr0b2
  - Fabp6
  - Ptprv
  - Mcf2l
  - Slc51b
  - ba
  - Errfi1
  - Fgf19
  - Lce1e
  - CYP7A1
  - FGFR4
  - KLB
  - FGF19
  - SLURP1
  - NR1H4
  - ABCB11
  - GCG
  - GLP1R
  - ZGLP1
  - ELL
  - NR0B2
  - FABP6
  - DDOST
  - MCF2L
  - SLC51B
---
